Blog
RSS FeedPosted by Michael Wonder on 26 Jun 2019
CMS approves Louisiana State Plan Amendment for supplemental rebate agreements using a modified subscription model for hepatitis C therapies in Medicaid
26 June 2019 - State Plan Amendment permits Louisiana to negotiate supplemental drug rebates to assist the state in controlling expenditures ...
Posted by Michael Wonder on 25 Jun 2019
Louisiana's experiment paying for hepatitis C drugs: lessons for other states, other treatments?
24 June 2019 - Beginning July 1 the Louisiana Department of Health will be implementing a groundbreaking licensing deal. ...
Posted by Michael Wonder on 21 May 2019
Louisiana is creating a drug price revolution
20 May 2019 - Louisiana is putting the final touches on a revolutionary deal that promises to simultaneously control health ...
Posted by Michael Wonder on 28 Mar 2019
Louisiana picks drug company for hepatitis C treatment plan
26 March 2019 - Louisiana has picked a pharmaceutical company for its unusual plan to broaden access to hepatitis C ...
Posted by Michael Wonder on 04 May 2017
Louisiana proposes tapping a century-old patent law to cut hepatitis C drug prices
2 May 2017 - Continuing public concerns over high-priced hepatitis C drugs are taking a new twist as Louisiana’s top ...